| Severe acute meningo-encephalo-myelitis: think anti-GFAP! A Sellimi, S Barthez, S Ferrao Santos, X Wittebole, S El Sankari Acta Neurologica Belgica, 1-4, 2024 | | 2024 |
| Multiple Sclerosis Multidisciplinary Care: A National Survey and Lessons for the Global Community L Van Hijfte, M Cambron, B Capron, B Dachy, D Decoo, D Dive, B Dubois, ... Multiple sclerosis and related disorders 85, 105540, 2024 | | 2024 |
| Long-term follow up of alemtuzumab-treated patients: a retrospective study in a Belgian tertiary care center V Van Pesch, AR Hanganu, SE Sankari Acta Neurologica Belgica, 1-12, 2024 | | 2024 |
| Évolution des troubles cognitifs dans la SEP: des trajectoires hétérogènes? F London, G Landenne, Z Benyahia, V Van Pesch, S El Sankari Revue Neurologique 180, S141, 2024 | | 2024 |
| Cognitive trajectories in relapsing-remitting multiple sclerosis: Evidence of multiple evolutionary trends F London, A De Haan, Z Benyahia, G Landenne, T Duprez, V van Pesch, ... Multiple sclerosis and related disorders 77, 104848, 2023 | 4 | 2023 |
| B cell depletion therapy does not resolve chronic active multiple sclerosis lesions P Maggi, CV Bulcke, E Pedrini, C Bugli, A Sellimi, M Wynen, A Stölting, ... EBioMedicine 94, 2023 | 19 | 2023 |
| Patient-reported outcome measurements in a selective cohort of relapsing–remitting multiple sclerosis patients: relationships with physical disability, cognitive impairment … F London, S El Sankari, A De Haan, Z Benyahia, G Landenne, T Duprez, ... Acta Neurologica Belgica 123 (3), 1049-1059, 2023 | 2 | 2023 |
| Les altérations cognitives dans la SEP: des trajectoires hétérogènes? F London, S El Sankari, G Landenne, Z Benyahia, V Van Pesch Revue Neurologique 179, S164, 2023 | | 2023 |
| Treatment satisfaction is associated with various PROMs in patients with relapsing-remitting multiple sclerosis F London, S El Sankari, G Landenne, Z Benyahia, V van Pesch MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 1006-1006, 2022 | | 2022 |
| MRI detected cortical lesions are associated with higher serum neurofilament levels in multiple sclerosis O Perdaens, C Vanden Bulcke, G Duchene, G Landenne, HA Dang, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 286-287, 2022 | | 2022 |
| A multi-stakeholder survey on multiple sclerosis multidisciplinary care: The situation in Belgium and lessons for the global community L Van Hijfte, M Cambron, B Capron, B Dachy, D Decoo, D Dive, B Dubois, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 402-403, 2022 | | 2022 |
| Chronic active multiple sclerosis lesions are poorly responsive to anti-CD20 antibody treatment P Maggi, C Vanden Bulcke, E Pedrini, C Bugli, A Sellimi, M Wynen, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 91-92, 2022 | 1 | 2022 |
| Relationships between employment status and patient-reported outcome and objective cognitive measures in patients with relapsing-remitting multiple sclerosis F London, S El Sankari, G Landenne, Z Benyahia, V van Pesch MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 1014-1014, 2022 | | 2022 |
| Patient-reported outcome measures do not predict cognitive impairment in relapsing MS patients F London, S El Sankari, G Landenne, Z Benyahia, V van Pesch MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 1015-1016, 2022 | | 2022 |
| Relapsing-remitting Optic Neuropathy in an HIV-infected Patient: Secondary Auto-immune Optic Neuropathy or Infectious Optic Neuropathy? A Case Report and Review of the Literature M Coutel, R Flamant, S El Sankari, L Belkhir, T Duprez, A Boschi Neuro-Ophthalmology 46 (4), 236-241, 2022 | | 2022 |
| Cutaneous diseases related to a hyperactive T-cell response in ocrelizumab-treated multiple sclerosis patients SE Sankari, C Van Essche, V Van Pesch Journal of neurology 268 (11), 4376-4378, 2021 | 2 | 2021 |
| MRI enlarged perivascular spaces in MS M Pasi, M Wynen, V Lolli, F Guisset, A Sellimi, S El Sankari, G Perrotta, ... MULTIPLE SCLEROSIS JOURNAL 27 (2_ SUPPL), 443-444, 2021 | | 2021 |
| Patient-reported outcome measures reflect multiple sclerosis-related disability F London, A Wisniewska, S El Sankari, V van Pesch MULTIPLE SCLEROSIS JOURNAL 27 (2_ SUPPL), 301-301, 2021 | | 2021 |
| Chronic active MRI lesions in multiple sclerosis patients undergoing anti-CD20 antibody therapies A Ben Ayad, A Sellimi, M Wynen, C Bugli, WA Mullins, G Kalaitzidis, ... MULTIPLE SCLEROSIS JOURNAL 27 (2_ SUPPL), 476-477, 2021 | | 2021 |
| Effects of prolonged-release fampridine on multiple sclerosis-related gait impairments. a crossover, double-blinded, placebo-controlled study M Valet, S El Sankari, V Van Pesch, C Detrembleur, T Lejeune, ... Clinical Biomechanics 86, 105382, 2021 | 4 | 2021 |
